Abstract
About 20% to 30% of colon cancer patients classified as node negative by routine hematoxylin-eosin (H&E) staining are found to have micrometastases (MM) or isolated tumor cells (ITC) in sentinel lymph nodes (SLNs) if analyzed by step sections and immunohistochemistry (IHC). Whether SLNs are in this respect representative for all lymph nodes was addressed in this study. SLNs were identified using the intraoperative blue dye detection technique. If all lymph nodes (SLNs and non-SLNs) of a patient were negative by routine H&E staining, they were step-sectioned and analyzed by IHC using pancytokeratin antibodies. We identified at least one SLN in 47 of the 55 patients (85%) and examined a median of 26 lymph nodes per patient (range 10–59). By routine H&E staining, 14 of the 47 patients showed lymph node metastases (30%); the remaining 33 were classified as node-negative. In this group (33 patients), 1011 lymph nodes were analyzed by step sections and IHC: 14 of 70 SLNs. (20%) but only 37 of 941 non-SLNs (4%) had MM/ITC (p < 0.001). Furthermore, 13 of the 33 H&E-negative patients were found to have MM/ITC (39%). In 11 of the 13 patients, MM/ITC were identified in both SLNs and non-SLNs in 1 patient in the SLN only, and in 1 patient in a non-SLN only (sensitivity for the identification of MM/ITC: 92%; negative predictive value: 95%). The SLN biopsy is a valid tool to detect, as well as exclude, the presence of MM/ITC in colon cancer patients. Our results may be of prognostic relevance and influence patient stratification for adjuvant therapy trials.
Similar content being viewed by others
References
Greenson JK, Craig EI, Rice R, et al. Identification of occult micrometastases in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 1994;73:563–569
Clarke G, Ryan E, Crowe J, et al. Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage 2 colorectal cancer. Eur. J .Histochem. 1999;43:311–316
Broll R, Schauer V, Schimmelpenning H, et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas. Dis. Colon Rectum 1997;401:1465–1471
Noura S, Yamamoto Y, Ohnishi T, et al. Comparative detection of lymph node micrometastases of stage 2 colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J. Clin. Oncol. 2002;20:4232–4241
Rosenberg R, Friederichs J, Gertler R, et al. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int. J. Colorectal Dis. 2004;19:430–437
Schulze T, Bembenek A, Schlag PM. Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbeck’s Arch. Surg. 2004;389:532–550
Schlag PM, Bembenek A, Schulze T. Sentinel node biopsy in gastrointestinal-tract cancer. Eur. J. Cancer 2004;40:2022–2032
Wood TF, Nora DT, Morton DL, et al. One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: detection of missed micrometastases. J. Gastrointest. Surg. 2002;6:322–330
Bilchik AJ, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter trial. J. Clin. Oncol. 2001;19:1128–1136
Trocha SD, Nora DT, Saha SS, et al. Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer. J. Gastrointest. Surg. 2003;7:340–346
Bilchik AJ, Nora DT, Sobin LH, et al. Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. J. Clin. Oncol. 2003;21:668–672
Bembenek A, Schneider U, Gretschel S, et al. Optimization of staging in colon cancer using sentinel lymph node biopsy. Chirurg 2005;75:761–766
Paramo JC, Summerall J, Poppiti R, et al. Validation of sentinel node mapping in patients with colon cancer. Ann. Surg. Oncol. 2002;9:550–554
Bell SW, Mourra N, Flejou JF, et al. Ex vivo sentinel lymph node mapping in colorectal cancer. Dis. Colon Rectum 2005;48:74–79
Meyer JS. Sentinel lymph node biopsy: strategies for pathologic examination of the specimen. J. Surg. Oncol. 2001;69:212–218
Hermanek P, Hutter RV, Sobin LH, et al. International Union Against Cancer: classification of isolated tumor cells and micrometastasis. Cancer 1999;86:2668–2673
Bertagnolli M, Miedema B, Redston M, et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann. Surg. 2004;240:624–630
Braat AE, Oosterhuis JW, Moll FC, et al. Successful sentinel node identification in colon carcinoma using Patentblue V. Eur. J. Surg. Oncol. 2004;30:633–637
Saha S, Monson KM, Bilchik A, et al. Comparative analysis of nodal upstaging between colon and rectal cancers by sentinel lymph node mapping: a prospective trail. Dis. Colon Rectum 2004;47:1767–1772
Read T, Fleshman JW, Caushaj PF. Sentinel lymph node mapping for adenocarcinoma of the colon does not improve staging accuracy. Dis. Colon Rectum 2005;48:80–85
Johnson DS, Wong JH. The impact on nodal staging of lymphatic mapping in carcinoma of the colon and rectum. Semin. Oncol. 2004;31:403–408
Turner RR, Nora DT, Trocha SD, et al. Colorectal carcinoma nodal staging: frequency and nature of cytokeratin-positive cells in sentinel and nonsentinel lymph nodes. Arch. Pathol. Lab. Med. 2003;127:673–679
Chu KU, Turner RR, Hansen NM, et al. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemical detectable nonsentinel node metastasis. Ann. Surg. Oncol. 1999;6:756–761
Chu KU, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann. Surg. 1999;229:536–541
Turner RR, Ollila DS, Krasne DL, et al. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann. Surg. 1997;226:271–278
Diaz NM, Cox CE, Ebert M, et al. Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am. J. Surg. Pathol. 2004;28:1641–1645
International Breast Cancer Study Group. Prognostic importance of occult axillary lymph ode micrometastases from breast cancers. Lancet 1990;335:1565–1568
Cote JR, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet 1999;354:896–900
Greene FL, Balch CM, Fleming A, et al. AJCC Cancer Staging Manual; American Joint Committee on Cancer, 6th edition, Berlin, Springer-Verlag, 2002
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bembenek, A., Schneider, U., Gretschel, S. et al. Detection of Lymph Node Micrometastases and Isolated Tumor Cells in Sentinel and Nonsentinel Lymph Nodes of Colon Cancer Patients. World J. Surg. 29, 1172–1175 (2005). https://doi.org/10.1007/s00268-005-0094-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-005-0094-x